|
End-of-day quote
Nasdaq Stockholm
2026-10-02
|
5-day change | 1st Jan Change | ||
| 3.790 SEK | -0.92% |
|
-6.77% | -17.61% |
| 10-05 | 23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-30 | Analyst recommendations: Apple, Walt Disney, Nvidia, Tesla, Fair Isaac… |  |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 101.1 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | -16.63% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 101.1 | 101.1 | 101.1 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | -16.63% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -6.16x |
| EV / Revenue | - | - | - | - | - | - | - | -6.16x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -2.9x | 6.09x | 2.01x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.04x | 5.55x | 1.95x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 3.835 | 3.835 | 3.835 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 3/25/22 | 2/9/23 | 2/8/24 | 2/13/25 | 4/1/26 | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 10.07M | |
| 21.73x | 7.72x | 15.51x | 1.37% | 74.31B | |
| 29.59x | 8.5x | 26.48x | 0.04% | 56.95B | |
| 33.52x | 6.02x | 18.04x | 0.97% | 48.3B | |
| -21.51x | 223.61x | -23.09x | -.--% | 44.51B | |
| 34.27x | 3.31x | 14.29x | -.--% | 43.8B | |
| 47.24x | 5.47x | 29.99x | -.--% | 41.12B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 31.07B | |
| 33.5x | 7.16x | 18.6x | -.--% | 28.97B | |
| -15.28x | 5.82x | -7.31x | -.--% | 24.53B | |
| Average | 21.19x | 30.62x | 12.55x | 0.31% | 39.36B | |
| Weighted average by Cap. | 22.51x | 31.17x | 13.62x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
